Global Health System Changes Could Affect Access to Medicines in South Africa

Health policy experts are warning that major changes in global health funding, international partnerships, and pharmaceutical supply chains could affect access to essential medicines in countries such as South Africa. Many health programmes in the country rely partly on international funding and research partnerships to support treatment and prevention efforts for diseases like HIV, tuberculosis and malaria. Analysts say reductions or restructuring of global health funding could disrupt clinical research, treatment programmes and supply systems that millions of patients depend on. Researchers also note that a significant portion of HIV and TB research and treatment support in South Africa have historically come from international partners, meaning funding changes could impact both scientific studies and access to life-saving medicines if alternative funding sources are not secured. Experts stress that strengthening local health systems, improving medicine supply chains and investing in domestic healthcare infrastructure will be critical to ensuring stable access to treatments in the future.